MXRA7 and Duchenne muscular dystrophy: Investigating MXRA7 as a potential blood/serum biomarker for fibrosis in DMD patients, along with identifying the specific cellular subpopulation(s) responsible for its expression, holds significant promise to enhance our comprehension of fibrotic processes and, more importantly, to develop clinical strategies to counteract fibrosis.